Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (27161)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Mar 7, 2016 (publication date) through Jun 29, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Nielsen MFB, Mortensen MB, Detlefsen S. Key players in pancreatic cancer-stroma interaction: Cancer-associated fibroblasts, endothelial and inflammatory cells. World J Gastroenterol 2016; 22(9): 2678-2700 [PMID: 26973408 DOI: 10.3748/wjg.v22.i9.2678] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i9/2678.htm |
| Number | Citing Articles |
| 1 |
Han-xiang Zhan, Bin Zhou, Yu-gang Cheng, Jian-wei Xu, Lei Wang, Guang-yong Zhang, San-yuan Hu. Crosstalk between stromal cells and cancer cells in pancreatic cancer: New insights into stromal biology. Cancer Letters 2017; 392: 83 doi: 10.1016/j.canlet.2017.01.041
|
| 2 |
Qiaofei Liu, Quan Liao, Yupei Zhao. Chemotherapy and tumor microenvironment of pancreatic cancer. Cancer Cell International 2017; 17(1) doi: 10.1186/s12935-017-0437-3
|
| 3 |
Enrico Pierluigi Spugnini, Mariantonia Logozzi, Rossella Di Raimo, Davide Mizzoni, Stefano Fais. A Role of Tumor-Released Exosomes in Paracrine Dissemination and Metastasis. International Journal of Molecular Sciences 2018; 19(12): 3968 doi: 10.3390/ijms19123968
|
| 4 |
Tianqi Su, Bo Yang, Tianren Gao, Tongjun Liu, Jiannan Li. Polymer nanoparticle-assisted chemotherapy of pancreatic cancer. Therapeutic Advances in Medical Oncology 2020; 12 doi: 10.1177/1758835920915978
|
| 5 |
Bin Zeng, Qiting Zhao, Zhiwei Sun, Doudou Liu, Hao Chen, Xiaoshuang Li, Jianyu Wang, H. Rosie Xing. SEC23A Is an Independent Prognostic Biomarker in Bladder Cancer Correlated With MAPK Signaling. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.672832
|
| 6 |
Ashenafi Bulle, Kian-Huat Lim. Beyond just a tight fortress: contribution of stroma to epithelial-mesenchymal transition in pancreatic cancer. Signal Transduction and Targeted Therapy 2020; 5(1) doi: 10.1038/s41392-020-00341-1
|
| 7 |
Yufu Wang, Tianyi Fang, Lining Huang, Hao Wang, Lei Zhang, Zhidong Wang, Yunfu Cui. Neutrophils infiltrating pancreatic ductal adenocarcinoma indicate higher malignancy and worse prognosis. Biochemical and Biophysical Research Communications 2018; 501(1): 313 doi: 10.1016/j.bbrc.2018.05.024
|
| 8 |
Ryo Koba, Hayato Fujita, Maiko Nishibori, Kiyoshi Saeki, Kinuko Nagayoshi, Yoshihiko Sadakari, Shuntaro Nagai, Oki Sekizawa, Kiyofumi Nitta, Tatsuya Manabe, Takashi Ueki, Tatsuhiro Ishida, Yoshinao Oda, Masafumi Nakamura. Quantitative evaluation of the intratumoral distribution of platinum in oxaliplatin‐treated rectal cancer: In situ visualization of platinum via synchrotron radiation X‐ray fluorescence spectrometry. International Journal of Cancer 2020; 146(9): 2498 doi: 10.1002/ijc.32592
|
| 9 |
Yiqiu Li, Fangfang Chen, Jun Chen, Siocheong Chan, Yi He, Wanli Liu, Ge Zhang. Disulfiram/Copper Induces Antitumor Activity against Both Nasopharyngeal Cancer Cells and Cancer-Associated Fibroblasts through ROS/MAPK and Ferroptosis Pathways. Cancers 2020; 12(1): 138 doi: 10.3390/cancers12010138
|
| 10 |
Olalekan H. Usman, Sampath Kumar, Reddick R. Walker, Gengqiang Xie, Hyeje C. Sumajit, AbdelAziz R. Jalil, Subramanian Ramakrishnan, Lawrence J. Dooling, Yue Julia Wang, Jerome Irianto, Kandice Tanner. Differential modulation of cellular phenotype and drug sensitivity by extracellular matrix proteins in primary and metastatic pancreatic cancer cells. Molecular Biology of the Cell 2023; 34(13) doi: 10.1091/mbc.E23-02-0075
|
| 11 |
Qiang Luo, Ziquan Hu, Hongcheng Zhao, Yanmei Fan, Xiancong Tu, Yueqing Wang, Xiaowen Liu. The role of TGF-β in the tumor microenvironment of pancreatic cancer. Genes & Diseases 2023; 10(4): 1513 doi: 10.1016/j.gendis.2022.10.019
|
| 12 |
Katherine Richards, Weikun Xiao, Reginald Hill. Cancer-Associated Fibroblasts Confer Gemcitabine Resistance to Pancreatic Cancer Cells through PTEN-Targeting miRNAs in Exosomes. Cancers 2022; 14(11): 2812 doi: 10.3390/cancers14112812
|
| 13 |
Jin Hong Lim, Joon Seong Park, Dong Sup Yoon. Preoperative fecal elastase-1 is a useful prognostic marker following curative resection of pancreatic cancer. HPB 2017; 19(5): 388 doi: 10.1016/j.hpb.2016.12.007
|
| 14 |
Ying Ma, Xiang Zhou. Spatially informed cell-type deconvolution for spatial transcriptomics. Nature Biotechnology 2022; 40(9): 1349 doi: 10.1038/s41587-022-01273-7
|
| 15 |
Letizia Porcelli, Rosa Maria Iacobazzi, Roberta Di Fonte, Simona Serratì, Angelica Intini, Antonio Giovanni Solimando, Oronzo Brunetti, Angela Calabrese, Francesco Leonetti, Amalia Azzariti, Nicola Silvestris. CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer. Cancers 2019; 11(3): 330 doi: 10.3390/cancers11030330
|
| 16 |
Myrna Hurtado, Sunil Shah, Maya Nair, Riyaz Basha. Breaking Tolerance to Pancreatic Cancer Unresponsiveness to Chemotherapy. 2019; : 13 doi: 10.1016/B978-0-12-817661-0.00002-0
|
| 17 |
Belén Toledo, Manuel Picon-Ruiz, Juan Antonio Marchal, Macarena Perán. Dual Role of Fibroblasts Educated by Tumour in Cancer Behavior and Therapeutic Perspectives. International Journal of Molecular Sciences 2022; 23(24): 15576 doi: 10.3390/ijms232415576
|
| 18 |
Kazuyoshi Noda, Yasushi Sato, Yasuyuki Okada, Kensei Nishida, Yutaka Kawano, Toshihito Tanahashi, Masahiro Bando, Koichi Okamoto, Masanori Takehara, Masahiro Sogabe, Hiroshi Miyamoto, Kei Daizumoto, Hiroomi Kanayama, Tetsuji Takayama. Exosomal miR‐199a‐3p Secreted From Cancer‐Associated Adipocytes Promotes Pancreatic Cancer Progression. Cancer Medicine 2024; 13(20) doi: 10.1002/cam4.70265
|
| 19 |
Damián Sánchez-Ramírez, Rafael Medrano-Guzmán, Fernando Candanedo-González, Jazmín De Anda-González, Luis Enrique García-Rios, Vadim Pérez-Koldenkova, Marcos Gutiérrez-de la Barrera, Sara Rodríguez-Enríquez, Marco Velasco-Velázquez, Silvia Cecilia Pacheco-Velázquez, Patricia Piña-Sánchez, Héctor Mayani, Alejandro Gómez-Delgado, Alberto Monroy-García, Ana Karen Martínez-Lara, Juan José Montesinos. High expression of both desmoplastic stroma and epithelial to mesenchymal transition markers associate with shorter survival in pancreatic ductal adenocarcinoma. European Journal of Histochemistry 2022; 66(1) doi: 10.4081/ejh.2022.3360
|
| 20 |
Miriam Bazan-Peregrino, Rocio Garcia-Carbonero, Berta Laquente, Rafael Álvarez, Ana Mato-Berciano, Marta Gimenez-Alejandre, Sara Morgado, Alba Rodríguez-García, Maria V Maliandi, M Carmen Riesco, Rafael Moreno, Mireia M Ginestà, Mercedes Perez-Carreras, Joan B Gornals, Susana Prados, Sofía Perea, Gabriel Capella, Ramon Alemany, Ramon Salazar, Emma Blasi, Carmen Blasco, Manel Cascallo, Manuel Hidalgo. VCN-01 disrupts pancreatic cancer stroma and exerts antitumor effects. Journal for ImmunoTherapy of Cancer 2021; 9(11): e003254 doi: 10.1136/jitc-2021-003254
|
| 21 |
Ning Pu, Qiangda Chen, Hanlin Yin, Jicheng Zhang, Guochao Zhao, Joseph R. Habib, Jie Chen, Jun Yu, Wenhui Lou, Wenchuan Wu. Identification of an Immune-Related BAT Signature for Predicting Adjuvant Chemotherapy Response and Overall Survival in Patients with Resected Ductal Adenocarcinoma of the Pancreas. Journal of Gastrointestinal Surgery 2022; 26(4): 869 doi: 10.1007/s11605-021-05232-6
|
| 22 |
Weikun Xiao, Mahsa Pahlavanneshan, Chae-Young Eun, Xinyu Zhang, Charlene DeKalb, Bayan Mahgoub, Hanaa Knaneh-Monem, Sana Shah, Alireza Sohrabi, Stephanie K. Seidlits, Reginald Hill. Matrix stiffness mediates pancreatic cancer chemoresistance through induction of exosome hypersecretion in a cancer associated fibroblasts-tumor organoid biomimetic model. Matrix Biology Plus 2022; 14: 100111 doi: 10.1016/j.mbplus.2022.100111
|
| 23 |
Vimal Arora, Dinesh Kumar Chellappan, Krishnan Anand, Harish Dureja. Advanced Drug Delivery Systems in the Management of Cancer. 2021; : 243 doi: 10.1016/B978-0-323-85503-7.00030-4
|
| 24 |
Xuan Li, Yincai Tang, Jingsi Ming, Xingjie Shi. A Bayesian hierarchical model with spatially varying dispersion for reference-free cell type deconvolution in spatial transcriptomics. Statistical Theory and Related Fields 2025; 9(2): 178 doi: 10.1080/24754269.2025.2495651
|
| 25 |
Ishan Roy, Kathleen A Boyle, Emily P Vonderhaar, Noah P Zimmerman, Egal Gorse, A Craig Mackinnon, Rosa F Hwang, Janusz Franco-Barraza, Edna Cukierman, Susan Tsai, Douglas B Evans, Michael B Dwinell. Cancer cell chemokines direct chemotaxis of activated stellate cells in pancreatic ductal adenocarcinoma. Laboratory Investigation 2017; 97(3): 302 doi: 10.1038/labinvest.2016.146
|
| 26 |
Syue-Ting Chen, Ting-Chun Kuo, Ying-Yu Liao, Mei-Chun Lin, Yu-Wen Tien, Min-Chuan Huang. Silencing of MUC20 suppresses the malignant character of pancreatic ductal adenocarcinoma cells through inhibition of the HGF/MET pathway. Oncogene 2018; 37(46): 6041 doi: 10.1038/s41388-018-0403-0
|
| 27 |
Masanori Takehara, Yasushi Sato, Tetsuo Kimura, Kazuyoshi Noda, Hiroshi Miyamoto, Yasuteru Fujino, Jinsei Miyoshi, Fumika Nakamura, Hironori Wada, Yoshimi Bando, Tetsuya Ikemoto, Mitsuo Shimada, Naoki Muguruma, Tetsuji Takayama. Cancer‐associated adipocytes promote pancreatic cancer progression through SAA1 expression. Cancer Science 2020; 111(8): 2883 doi: 10.1111/cas.14527
|
| 28 |
Frederick De Miollis, Zied Souguir, Charles Poiraud, Joseph de Saxce, Lucie Dercourt, Elodie Vandenhaute, Audrey Vincent, Nathalie Maubon, Isabelle Van Seuningen, Vincent Senez. Engineering Microscale Biomimetic Hydroscaffold for Dynamic Three-Dimensional Modeling of Pancreatic Cancer. 2021 IEEE 34th International Conference on Micro Electro Mechanical Systems (MEMS) 2021; : 407 doi: 10.1109/MEMS51782.2021.9375317
|
| 29 |
Raffaella Belvedere, Valentina Bizzarro, Giovanni Forte, Fabrizio Dal Piaz, Luca Parente, Antonello Petrella. Annexin A1 contributes to pancreatic cancer cell phenotype, behaviour and metastatic potential independently of Formyl Peptide Receptor pathway. Scientific Reports 2016; 6(1) doi: 10.1038/srep29660
|
| 30 |
Eduardo Mere Del Aguila. Retinoic acid receptor-β deletion in a model of early pancreatic ductal adenocarcinoma (PDAC) tumorigenesis. American Journal of Cancer Research 2025; 15(1): 127 doi: 10.62347/XFOT8509
|
| 31 |
Michael Orth, Philipp Metzger, Sabine Gerum, Julia Mayerle, Günter Schneider, Claus Belka, Maximilian Schnurr, Kirsten Lauber. Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches. Radiation Oncology 2019; 14(1) doi: 10.1186/s13014-019-1345-6
|
| 32 |
Qianwen Yu, Yue Qiu, Jianping Li, Xian Tang, Xuhui Wang, Xingli Cun, Shanshan Xu, Yayuan Liu, Man Li, Zhirong Zhang, Qin He. Targeting cancer-associated fibroblasts by dual-responsive lipid-albumin nanoparticles to enhance drug perfusion for pancreatic tumor therapy. Journal of Controlled Release 2020; 321: 564 doi: 10.1016/j.jconrel.2020.02.040
|
| 33 |
Edward P. Carter, Abigail S. Coetzee, Elena Tomas Bort, Qiaoying Wang, Hemant M. Kocher, Richard P. Grose. Dissecting FGF Signalling to Target Cellular Crosstalk in Pancreatic Cancer. Cells 2021; 10(4): 847 doi: 10.3390/cells10040847
|
| 34 |
Shirin Hafezi, Maha Saber-Ayad, Wael M. Abdel-Rahman. Highlights on the Role of KRAS Mutations in Reshaping the Microenvironment of Pancreatic Adenocarcinoma. International Journal of Molecular Sciences 2021; 22(19): 10219 doi: 10.3390/ijms221910219
|
| 35 |
Ella Kesti, Emmy Borgmästars, Jaana Hagström, Harri Mustonen, Hanna Seppänen, Caj Haglund, Malin Sund. The Prognostic Significance of Collagen VI in Pancreatic Ductal Adenocarcinoma. Pancreas 2024; 53(9): e729 doi: 10.1097/MPA.0000000000002360
|
| 36 |
Yaohui Fang, Chunlu Tan, Zhenjiang Zheng, Jianchen Yang, Jiali Tang, Ruizhe Guo, Epiphane K. Silli, Zhe Chen, Jia Chen, Ruyu Ge, Yuquan Liu, Xiuqi Wen, Jingdan Liang, Yunfei Zhu, Yutong Jin, Qian Li, Ying Wang. The function of microRNA related to cancer-associated fibroblasts in pancreatic ductal adenocarcinoma. Biochemical Pharmacology 2025; 236: 116849 doi: 10.1016/j.bcp.2025.116849
|
| 37 |
Xiaoqin Ji, Xixu Zhu, Xueguan Lu. Effect of cancer-associated fibroblasts on radiosensitivity of cancer cells. Future Oncology 2017; 13(17): 1537 doi: 10.2217/fon-2017-0054
|
| 38 |
Hirobumi Fuchigami, Shino Manabe, Masahiro Yasunaga, Yasuhiro Matsumura. Chemotherapy payload of anti-insoluble fibrin antibody-drug conjugate is released specifically upon binding to fibrin. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-32601-0
|
| 39 |
Caroline Y. K. Fong, Emma Burke, David Cunningham, Naureen Starling. Up-to-Date Tailored Systemic Treatment in Pancreatic Ductal Adenocarcinoma. Gastroenterology Research and Practice 2019; 2019: 1 doi: 10.1155/2019/7135437
|
| 40 |
Mingyi Shang, Li Weng, Guifang Xu, Shaoqiu Wu, Bingyan Liu, Xiang Yin, Aiwu Mao, Xiaoping Zou, Zhongmin Wang. TRIM11 suppresses ferritinophagy and gemcitabine sensitivity through UBE2N/TAX1BP1 signaling in pancreatic ductal adenocarcinoma. Journal of Cellular Physiology 2021; 236(10): 6868 doi: 10.1002/jcp.30346
|
| 41 |
Judith Vinaixa, Neus Martínez-Bosch, Joan Gibert, Noemí Manero-Rupérez, Patricia Santofimia-Castaño, Federico G. Baudou, Renzo E. Vera, David R. Pease, Mar Iglesias, Sandhya Sen, Xiyin Wang, Luciana L. Almada, David L. Marks, Mireia Moreno, Juan L. Iovanna, Gabriel A. Rabinovich, Martin E. Fernandez-Zapico, Pilar Navarro.
Nuclear Galectin-1 promotes
KRAS
-dependent activation of pancreatic cancer stellate cells
. Proceedings of the National Academy of Sciences 2025; 122(14) doi: 10.1073/pnas.2424051122
|
| 42 |
Nicola Gaianigo, Davide Melisi, Carmine Carbone. EMT and Treatment Resistance in Pancreatic Cancer. Cancers 2017; 9(9): 122 doi: 10.3390/cancers9090122
|
| 43 |
Zhenfei Wang, Daguang Ma, Changshan Wang, Zhe Zhu, Yongyan Yang, Fenfang Zeng, Jianlong Yuan, Xia Liu, Yue Gao, Yongxia Chen, Yongfeng Jia. Triptonide inhibits the pathological functions of gastric cancer-associated fibroblasts. Biomedicine & Pharmacotherapy 2017; 96: 757 doi: 10.1016/j.biopha.2017.10.046
|
| 44 |
Xianwen Hu, Xiaotian Li, Pan Wang, Jiong Cai. The Role of FAPI PET Imaging in Pancreatic Cancer: A Meta-analysis Compared with 18F-FDG PET. Academic Radiology 2025; 32(1): 191 doi: 10.1016/j.acra.2024.07.032
|
| 45 |
Alessandro Olivari, Virginia Agnetti, Ingrid Garajová. Focus on Therapeutic Options for Surgically Resectable Pancreatic Adenocarcinoma Based on Novel Biomarkers. Current Oncology 2023; 30(7): 6462 doi: 10.3390/curroncol30070475
|
| 46 |
Chun-Yi Chang, Chien-Chi Lin. Hydrogel Models with Stiffness Gradients for Interrogating Pancreatic Cancer Cell Fate. Bioengineering 2021; 8(3): 37 doi: 10.3390/bioengineering8030037
|
| 47 |
Sonia Perales, Carolina Torres, Cristina Jimenez-Luna, Jose Prados, Joaquina Martinez-Galan, Jose Manuel Sanchez-Manas, Octavio Caba. Liquid biopsy approach to pancreatic cancer. World Journal of Gastrointestinal Oncology 2021; 13(10): 1263-1287 doi: 10.4251/wjgo.v13.i10.1263
|
| 48 |
Satya Das, Jordan Berlin, Dana Cardin. Harnessing the Immune System in Pancreatic Cancer. Current Treatment Options in Oncology 2018; 19(10) doi: 10.1007/s11864-018-0566-5
|
| 49 |
Xiaoxiao Chen, Qianwen Yu, Yinke Liu, Qinglin Sheng, Kairong Shi, Yang Wang, Man Li, Zhirong Zhang, Qin He. Synergistic cytotoxicity and co-autophagy inhibition in pancreatic tumor cells and cancer-associated fibroblasts by dual functional peptide-modified liposomes. Acta Biomaterialia 2019; 99: 339 doi: 10.1016/j.actbio.2019.09.003
|
| 50 |
Divya Thomas, Prakash Radhakrishnan. Tumor Microenvironment. Advances in Experimental Medicine and Biology 2020; 1234: 57 doi: 10.1007/978-3-030-37184-5_5
|
| 51 |
|
| 52 |
Aleksandra Adamska, Omar Elaskalani, Aikaterini Emmanouilidi, Minkyoung Kim, Norbaini Binti Abdol Razak, Pat Metharom, Marco Falasca. Molecular and cellular mechanisms of chemoresistance in pancreatic cancer. Advances in Biological Regulation 2018; 68: 77 doi: 10.1016/j.jbior.2017.11.007
|
| 53 |
Farid G Khalafalla, Mohammad W Khan. Inflammation and Epithelial-Mesenchymal Transition in Pancreatic Ductal Adenocarcinoma: Fighting Against Multiple Opponents. Cancer Growth and Metastasis 2017; 10: 117906441770928 doi: 10.1177/1179064417709287
|
| 54 |
Michael Friberg Bruun Nielsen, Michael Bau Mortensen, Sönke Detlefsen. Typing of pancreatic cancer-associated fibroblasts identifies different subpopulations. World Journal of Gastroenterology 2018; 24(41): 4663-4678 doi: 10.3748/wjg.v24.i41.4663
|
| 55 |
Carlo Fabbri, Giulia Gibiino, Adele Fornelli, Vincenzo Cennamo, Daniela Grifoni, Michela Visani, Giorgia Acquaviva, Matteo Fassan, Sirio Fiorino, Silvia Giovanelli, Marco Bassi, Stefania Ghersi, Giovanni Tallini, Elio Jovine, Antonio Gasbarrini, Dario de Biase. Team work and cytopathology molecular diagnosis of solid pancreatic lesions. Digestive Endoscopy 2017; 29(6): 657 doi: 10.1111/den.12845
|
| 56 |
Michael Karl Melzer, Frank Arnold, Katja Stifter, Friedemann Zengerling, Ninel Azoitei, Thomas Seufferlein, Christian Bolenz, Alexander Kleger. An Immunological Glance on Pancreatic Ductal Adenocarcinoma. International Journal of Molecular Sciences 2020; 21(9): 3345 doi: 10.3390/ijms21093345
|
| 57 |
Viola Sgarminato, Simone Luigi Marasso, Matteo Cocuzza, Giorgio Scordo, Alberto Ballesio, Gianluca Ciardelli, Chiara Tonda-Turo. PDAC-on-chip for in vitro modeling of stromal and pancreatic cancer cell crosstalk. Biomaterials Science 2023; 11(1): 208 doi: 10.1039/D2BM00881E
|
| 58 |
Imke Stouten, Nadine van Montfoort, Lukas J. A. C. Hawinkels. The Tango between Cancer-Associated Fibroblasts (CAFs) and Immune Cells in Affecting Immunotherapy Efficacy in Pancreatic Cancer. International Journal of Molecular Sciences 2023; 24(10): 8707 doi: 10.3390/ijms24108707
|
| 59 |
Julie Dardare, Andréa Witz, Jean-Louis Merlin, Pauline Gilson, Alexandre Harlé. SMAD4 and the TGFβ Pathway in Patients with Pancreatic Ductal Adenocarcinoma. International Journal of Molecular Sciences 2020; 21(10): 3534 doi: 10.3390/ijms21103534
|
| 60 |
Minli Huang, Mengru Fu, Jia Wang, Chunhua Xia, Hong Zhang, Yuqing Xiong, Jiake He, Jianming Liu, Bingchen Liu, Siyi Pan, Fanglan Liu. TGF-β1-activated cancer-associated fibroblasts promote breast cancer invasion, metastasis and epithelial-mesenchymal transition by autophagy or overexpression of FAP-α. Biochemical Pharmacology 2021; 188: 114527 doi: 10.1016/j.bcp.2021.114527
|
| 61 |
Wei Cai, Yongjian Zhu, Dengfeng Li, Mancang Hu, Ze Teng, Rong Cong, Zhaowei Chen, Xujie Sun, Xiaohong Ma, Xinming Zhao. Baseline Body Composition and 3D-Extracellular Volume Fraction for Predicting Pancreatic Fistula after Distal Pancreatectomy in Pancreatic Body and/or Tail Adenocarcinoma. Academic Radiology 2025; 32(4): 2027 doi: 10.1016/j.acra.2024.10.010
|
| 62 |
Kai Wang, Hong He. Tumor Microenvironments in Organs. Advances in Experimental Medicine and Biology 2020; 1296: 243 doi: 10.1007/978-3-030-59038-3_15
|
| 63 |
Jérémy Nigri, Meritxell Gironella, Christian Bressy, Elena Vila-Navarro, Julie Roques, Sophie Lac, Caroline Bontemps, Coraline Kozaczyk, Jérôme Cros, Daniel Pietrasz, Raphaël Maréchal, Jean-Luc Van Laethem, Juan Iovanna, Jean-Baptiste Bachet, Emma Folch-Puy, Richard Tomasini. PAP/REG3A favors perineural invasion in pancreatic adenocarcinoma and serves as a prognostic marker. Cellular and Molecular Life Sciences 2017; 74(22): 4231 doi: 10.1007/s00018-017-2579-9
|
| 64 |
Zhiyuan Liu, Dafei Wu, Weiwei Zhai, Liang Ma. SONAR enables cell type deconvolution with spatially weighted Poisson-Gamma model for spatial transcriptomics. Nature Communications 2023; 14(1) doi: 10.1038/s41467-023-40458-9
|
| 65 |
Rachel L. O. Olson, Judith V. Forner, Pilar Navarro, Martin E. Fernandez-Zapico, Ahmed M. Elamir. Pancreatic Cancer. 2018; : 1 doi: 10.1007/978-1-4939-6631-8_89-1
|
| 66 |
Takashi Okumura, Kenoki Ohuchida, Shin Kibe, Chika Iwamoto, Yohei Ando, Shin Takesue, Hiromichi Nakayama, Toshiya Abe, Sho Endo, Kazuhiro Koikawa, Masafumi Sada, Kohei Horioka, Naoki Mochidome, Makoto Arita, Taiki Moriyama, Kohei Nakata, Yoshihiro Miyasaka, Takao Ohtsuka, Kazuhiro Mizumoto, Yoshinao Oda, Makoto Hashizume, Masafumi Nakamura. Adipose tissue‐derived stromal cells are sources of cancer‐associated fibroblasts and enhance tumor progression by dense collagen matrix. International Journal of Cancer 2019; 144(6): 1401 doi: 10.1002/ijc.31775
|
| 67 |
Hiromichi Nakayama, Kenoki Ohuchida, Masaki Yoshida, Tetsuyuki Miyazaki, Shin Takesue, Toshiya Abe, Sho Endo, Kazuhiro Koikawa, Takashi Okumura, Taiki Moriyama, Kohei Nakata, Yoshihiro Miyasaka, Kengo Shirahane, Tatsuya Manabe, Takao Ohtsuka, Hiroki Toma, Yohei Tominaga, Eishi Nagai, Kazuhiro Mizumoto, Yoshinao Oda, Masafumi Nakamura. Degree of desmoplasia in metastatic lymph node lesions is associated with lesion size and poor prognosis in pancreatic cancer patients. Oncology Letters 2017; 14(3): 3141 doi: 10.3892/ol.2017.6549
|
| 68 |
Rachel L. O. Olson, Judith V. Forner, Pilar Navarro, Martin E. Fernandez-Zapico, Ahmed M. Elamir. Pancreatic Cancer. 2018; : 539 doi: 10.1007/978-1-4939-7193-0_89
|
| 69 |
Thilo Hackert, Laura Wüsten, Markus W. Büchler. Tumor Angiogenesis. 2017; : 1 doi: 10.1007/978-3-319-31215-6_18-1
|
| 70 |
Lenka N.C. Boyd, Katarina D. Andini, Godefridus J. Peters, Geert Kazemier, Elisa Giovannetti. Heterogeneity and plasticity of cancer-associated fibroblasts in the pancreatic tumor microenvironment. Seminars in Cancer Biology 2022; 82: 184 doi: 10.1016/j.semcancer.2021.03.006
|
| 71 |
Khem Raj Limbu, Rashmi Bhandari Chhetri, Subin Kim, Jitendra Shrestha, Yoon Sin Oh, Dong Jae Baek, Eun-Young Park. Targeting sphingosine 1-phosphate and sphingosine kinases in pancreatic cancer: mechanisms and therapeutic potential. Cancer Cell International 2024; 24(1) doi: 10.1186/s12935-024-03535-7
|
| 72 |
Yizhen Pang, Liang Zhao, Tinghua Meng, Weizhi Xu, Qin Lin, Hua Wu, Jingjing Zhang, Xiaoyuan Chen, Long Sun, Haojun Chen. PET Imaging of Fibroblast Activation Protein in Various Types of Cancer Using68Ga-FAP-2286: Comparison with18F-FDG and68Ga-FAPI-46 in a Single-Center, Prospective Study. Journal of Nuclear Medicine 2023; 64(3): 386 doi: 10.2967/jnumed.122.264544
|
| 73 |
Manoj Amrutkar, Ivar P. Gladhaug. Stellate Cells Aid Growth-Permissive Metabolic Reprogramming and Promote Gemcitabine Chemoresistance in Pancreatic Cancer. Cancers 2021; 13(4): 601 doi: 10.3390/cancers13040601
|
| 74 |
Magdalena Swierczewska, Serguei Kozlov, Pavan P. Adiseshaiah. Oncogenomics. 2019; : 313 doi: 10.1016/B978-0-12-811785-9.00022-3
|
| 75 |
Yizhen Pang, Long Zhao, Qihang Shang, Tinghua Meng, Liang Zhao, Liuxing Feng, Shuangjia Wang, Ping Guo, Xiurong Wu, Qin Lin, Hua Wu, Weipeng Huang, Long Sun, Haojun Chen. Positron emission tomography and computed tomography with [68Ga]Ga-fibroblast activation protein inhibitors improves tumor detection and staging in patients with pancreatic cancer. European Journal of Nuclear Medicine and Molecular Imaging 2022; 49(4): 1322 doi: 10.1007/s00259-021-05576-w
|
| 76 |
Dimakatso Alice Senthebane, Arielle Rowe, Nicholas Ekow Thomford, Hendrina Shipanga, Daniella Munro, Mohammad A. M. Al Mazeedi, Hashim A. M. Almazyadi, Karlien Kallmeyer, Collet Dandara, Michael S. Pepper, M. Iqbal Parker, Kevin Dzobo. The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer. International Journal of Molecular Sciences 2017; 18(7): 1586 doi: 10.3390/ijms18071586
|
| 77 |
In Kuk Cho, Haeryoung Kim, Jong-chan Lee, Jongchan Lee, Jaihwan Kim, Soomin Ahn, Hyunjin Park, Jin-Hyeok Hwang. Higher Tumor Cellularity in Resected Pancreatic Ductal Adenocarcinoma Is a Negative Prognostic Indicator. Gut and Liver 2020; 14(4): 521 doi: 10.5009/gnl19180
|
| 78 |
Belinda Lee, Peter Gibbs. Inflammation, Biomarkers and Immuno-Oncology Pathways in Pancreatic Cancer. Journal of Personalized Medicine 2019; 9(2): 20 doi: 10.3390/jpm9020020
|
| 79 |
I. V. Alekseenko, T. V. Vinogradova, E. D. Sverdlov. Genetic Regulatory Mechanisms of Evolution and Embryogenesis in a Distorting Mirror of Carcinogenesis. Russian Journal of Genetics 2018; 54(2): 145 doi: 10.1134/S1022795418020023
|
| 80 |
Sho Endo, Kohei Nakata, Kenoki Ohuchida, Shin Takesue, Hiromichi Nakayama, Toshiya Abe, Kazuhiro Koikawa, Takashi Okumura, Masafumi Sada, Kohei Horioka, Biao Zheng, Yusuke Mizuuchi, Chika Iwamoto, Masaharu Murata, Taiki Moriyama, Yoshihiro Miyasaka, Takao Ohtsuka, Kazuhiro Mizumoto, Yoshinao Oda, Makoto Hashizume, Masafumi Nakamura. Autophagy Is Required for Activation of Pancreatic Stellate Cells, Associated With Pancreatic Cancer Progression and Promotes Growth of Pancreatic Tumors in Mice. Gastroenterology 2017; 152(6): 1492 doi: 10.1053/j.gastro.2017.01.010
|
| 81 |
Alex Ney, Ismahan Mahamed, Andres Garcia, Pal Selbo, Patricia Sancho, Alexander J. MacRobert, Stephen P. Pereira, Pilar Acedo, Tayyaba Hasan. Combination light-based therapies to treat pancreatic cancer: a proof of concept. 17th International Photodynamic Association World Congress 2019; : 124 doi: 10.1117/12.2525305
|
| 82 |
Asmita Chopra, Ruben Zamora, Yoram Vodovotz, Jacob C. Hodges, Derek Barclay, Randall Brand, Richard L. Simmons, Kenneth K Lee, Alessandro Paniccia, Pranav Murthy, Michael T. Lotze, Brian A. Boone, Amer H. Zureikat. Baseline Plasma Inflammatory Profile Is Associated With Response to Neoadjuvant Chemotherapy in Patients With Pancreatic Adenocarcinoma. Journal of Immunotherapy 2021; 44(5): 185 doi: 10.1097/CJI.0000000000000370
|
| 83 |
Iera Hernandez-Unzueta, Aitor Benedicto, Irene Romayor, Alba Herrero, Eduardo Sanz, Beatriz Arteta, Elvira Olaso, Joana Márquez. Ocoxin Oral Solution Exerts an Antitumoral Effect in Pancreatic Cancer and Reduces the Stromal-Mediated Chemoresistance. Pancreas 2019; 48(4): 555 doi: 10.1097/MPA.0000000000001277
|
| 84 |
Chung-Tzu Hsueh, Julie H Selim, James Y Tsai, Chung-Tsen Hsueh. Nanovectors for anti-cancer drug delivery in the treatment of advanced pancreatic adenocarcinoma. World Journal of Gastroenterology 2016; 22(31): 7080-7090 doi: 10.3748/wjg.v22.i31.7080
|
| 85 |
Fangkun Liu, Jing Huang, Bo Ning, Zhixiong Liu, Shen Chen, Wei Zhao. Drug Discovery via Human-Derived Stem Cell Organoids. Frontiers in Pharmacology 2016; 7 doi: 10.3389/fphar.2016.00334
|
| 86 |
Ran Xue, Lin Hua, Wenbin Xu, Yan Gao, Yanhua Pang, Jianyu Hao. Derivation and Validation of the Potential Core Genes in Pancreatic Cancer for Tumor-Stroma Crosstalk. BioMed Research International 2018; 2018: 1 doi: 10.1155/2018/4283673
|
| 87 |
Matthias Müller, Matthias Barone, Maarten van Dinther, Kathrin Motzny, Jiang Ren, Jenny Eichhorst, Dominik Albat, Slim Chiha, Martin Lehmann, Rudolf Volkmer, Hartmut Oschkinat, Hans-Günther Schmalz, Peter ten Dijke, Ronald Kühne. Ena/VASP-EVH1 inhibition prevents chemotaxis and metastasis by blocking the EVH1–WAVE2 interaction. Proceedings of the National Academy of Sciences 2025; 122(26) doi: 10.1073/pnas.2423512122
|
| 88 |
David L Marks, Rachel LO Olson, Martin E Fernandez-Zapico. Epigenetic Control of the Tumor Microenvironment. Epigenomics 2016; 8(12): 1671 doi: 10.2217/epi-2016-0110
|
| 89 |
Yutaro Hara, Hiroki Mizukami, Takahiro Yamada, Shuji Shimoyama, Keisuke Yamazaki, Takanori Sasaki, Zhenchao Wang, Hanae Kushibiki, Masaki Ryuzaki, Saori Ogasawara, Hiroaki Tamba, Akiko Itaya, Norihisa Kimura, Keinosuke Ishido, Shinya Ueno, Kenichi Hakamada. Type 2 diabetes alters quiescent pancreatic stellate cells to tumor-prone state. JCI Insight 2025; 10(12) doi: 10.1172/jci.insight.187424
|
| 90 |
Krzysztof Szymoński, Katarzyna Milian-Ciesielska, Ewelina Lipiec, Dariusz Adamek. Current Pathology Model of Pancreatic Cancer. Cancers 2022; 14(9): 2321 doi: 10.3390/cancers14092321
|
| 91 |
Zong-Ting Gu, Zong-Ze Li, Cheng-feng Wang. Advances in research of extracellular mechanisms underlying gemcitabine resistance in pancreatic cancer. World Chinese Journal of Digestology 2021; 29(8): 421 doi: 10.11569/wcjd.v29.i8.421
|
| 92 |
Xinlei Zou, Canghai Guan, Jianjun Gao, Wujiang Shi, Yunfu Cui, Xiangyu Zhong. Tertiary lymphoid structures in pancreatic cancer: a new target for immunotherapy. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1222719
|
| 93 |
Thilo Hackert, Laura Wüsten, Markus W. Büchler. Tumor Angiogenesis. 2019; : 415 doi: 10.1007/978-3-319-33673-2_18
|
| 94 |
Toshio Takahashi. Organoids for Drug Discovery and Personalized Medicine. Annual Review of Pharmacology and Toxicology 2019; 59(1): 447 doi: 10.1146/annurev-pharmtox-010818-021108
|
| 95 |
Alessandro Poggi, Serena Varesano, Maria Raffaella Zocchi. How to Hit Mesenchymal Stromal Cells and Make the Tumor Microenvironment Immunostimulant Rather Than Immunosuppressive. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.00262
|
| 96 |
Kivanc Görgülü, Kalliope N. Diakopoulos, Jiaoyu Ai, Benjamin Schoeps, Derya Kabacaoglu, Angeliki-Faidra Karpathaki, Katrin J. Ciecielski, Ezgi Kaya-Aksoy, Dietrich A. Ruess, Alexandra Berninger, Marlena Kowalska, Marija Stevanovic, Sonja M. Wörmann, Thomas Wartmann, Yue Zhao, Walter Halangk, Svetlana Voronina, Alexey Tepikin, Anna Melissa Schlitter, Katja Steiger, Anna Artati, Jerzy Adamski, Michaela Aichler, Axel Walch, Martin Jastroch, Götz Hartleben, Christos S. Mantzoros, Wilko Weichert, Roland M. Schmid, Stephan Herzig, Achim Krüger, Bruno Sainz, Marina Lesina, Hana Algül. Levels of the Autophagy-Related 5 Protein Affect Progression and Metastasis of Pancreatic Tumors in Mice. Gastroenterology 2019; 156(1): 203 doi: 10.1053/j.gastro.2018.09.053
|
| 97 |
Gemma van Duijneveldt, Michael D.W. Griffin, Tracy L. Putoczki. Emerging roles for the IL-6 family of cytokines in pancreatic cancer. Clinical Science 2020; 134(16): 2091 doi: 10.1042/CS20191211
|
| 98 |
Wei Mu, Zhe Wang, Margot Zöller. Ping-Pong—Tumor and Host in Pancreatic Cancer Progression. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.01359
|
| 99 |
Abigail Coetzee, Richard Grose, Hemant Kocher. Three Dimensional Human Organotypic Models for Biomedical Research. Current Topics in Microbiology and Immunology 2019; 430: 183 doi: 10.1007/82_2019_155
|
| 100 |
Micah N. Sagini, Michael Zepp, Frank Bergmann, Matthias Bozza, Richard Harbottle, Martin R. Berger. The expression of genes contributing to pancreatic adenocarcinoma progression is influenced by the respective environment. Genes & Cancer 2018; 9(3-4): 114 doi: 10.18632/genesandcancer.173
|
| 101 |
Jianhong An, Tingting Jiang, Ling Qi, Keping Xie. Acinar cells and the development of pancreatic fibrosis. Cytokine & Growth Factor Reviews 2023; : 40 doi: 10.1016/j.cytogfr.2023.05.003
|
| 102 |
Ayuko Hoshino, Han Sang Kim, Linda Bojmar, Kofi Ennu Gyan, Michele Cioffi, Jonathan Hernandez, Constantinos P. Zambirinis, Gonçalo Rodrigues, Henrik Molina, Søren Heissel, Milica Tesic Mark, Loïc Steiner, Alberto Benito-Martin, Serena Lucotti, Angela Di Giannatale, Katharine Offer, Miho Nakajima, Caitlin Williams, Laura Nogués, Fanny A. Pelissier Vatter, Ayako Hashimoto, Alexander E. Davies, Daniela Freitas, Candia M. Kenific, Yonathan Ararso, Weston Buehring, Pernille Lauritzen, Yusuke Ogitani, Kei Sugiura, Naoko Takahashi, Maša Alečković, Kayleen A. Bailey, Joshua S. Jolissant, Huajuan Wang, Ashton Harris, L. Miles Schaeffer, Guillermo García-Santos, Zoe Posner, Vinod P. Balachandran, Yasmin Khakoo, G. Praveen Raju, Avigdor Scherz, Irit Sagi, Ruth Scherz-Shouval, Yosef Yarden, Moshe Oren, Mahathi Malladi, Mary Petriccione, Kevin C. De Braganca, Maria Donzelli, Cheryl Fischer, Stephanie Vitolano, Geraldine P. Wright, Lee Ganshaw, Mariel Marrano, Amina Ahmed, Joe DeStefano, Enrico Danzer, Michael H.A. Roehrl, Norman J. Lacayo, Theresa C. Vincent, Martin R. Weiser, Mary S. Brady, Paul A. Meyers, Leonard H. Wexler, Srikanth R. Ambati, Alexander J. Chou, Emily K. Slotkin, Shakeel Modak, Stephen S. Roberts, Ellen M. Basu, Daniel Diolaiti, Benjamin A. Krantz, Fatima Cardoso, Amber L. Simpson, Michael Berger, Charles M. Rudin, Diane M. Simeone, Maneesh Jain, Cyrus M. Ghajar, Surinder K. Batra, Ben Z. Stanger, Jack Bui, Kristy A. Brown, Vinagolu K. Rajasekhar, John H. Healey, Maria de Sousa, Kim Kramer, Sujit Sheth, Jeanine Baisch, Virginia Pascual, Todd E. Heaton, Michael P. La Quaglia, David J. Pisapia, Robert Schwartz, Haiying Zhang, Yuan Liu, Arti Shukla, Laurence Blavier, Yves A. DeClerck, Mark LaBarge, Mina J. Bissell, Thomas C. Caffrey, Paul M. Grandgenett, Michael A. Hollingsworth, Jacqueline Bromberg, Bruno Costa-Silva, Hector Peinado, Yibin Kang, Benjamin A. Garcia, Eileen M. O’Reilly, David Kelsen, Tanya M. Trippett, David R. Jones, Irina R. Matei, William R. Jarnagin, David Lyden. Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers. Cell 2020; 182(4): 1044 doi: 10.1016/j.cell.2020.07.009
|
| 103 |
Sophie Liot, Jonathan Balas, Alexandre Aubert, Laura Prigent, Perrine Mercier-Gouy, Bernard Verrier, Philippe Bertolino, Ana Hennino, Ulrich Valcourt, Elise Lambert. Stroma Involvement in Pancreatic Ductal Adenocarcinoma: An Overview Focusing on Extracellular Matrix Proteins. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.612271
|
| 104 |
Karolina Najder, Boris Musset, Otto Lindemann, Etmar Bulk, Albrecht Schwab, Benedikt Fels. The function of TRP channels in neutrophil granulocytes. Pflügers Archiv - European Journal of Physiology 2018; 470(7): 1017 doi: 10.1007/s00424-018-2146-8
|
| 105 |
Marcel A. Heinrich, Ahmed M.R.H. Mostafa, Jennifer P. Morton, Lukas J.A.C. Hawinkels, Jai Prakash. Translating complexity and heterogeneity of pancreatic tumor: 3D in vitro to in vivo models. Advanced Drug Delivery Reviews 2021; 174: 265 doi: 10.1016/j.addr.2021.04.018
|
| 106 |
Xiao Sun, Nengyi Ni, Yanling Ma, Yan Wang, David Tai Leong. Retooling Cancer Nanotherapeutics’ Entry into Tumors to Alleviate Tumoral Hypoxia. Small 2020; 16(41) doi: 10.1002/smll.202003000
|
| 107 |
Amalia Azzariti, Rosa Maria Iacobazzi, Roberta Di Fonte, Letizia Porcelli, Roberto Gristina, Pietro Favia, Francesco Fracassi, Ilaria Trizio, Nicola Silvestris, Gabriella Guida, Stefania Tommasi, Eloisa Sardella. Plasma-activated medium triggers cell death and the presentation of immune activating danger signals in melanoma and pancreatic cancer cells. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-40637-z
|
| 108 |
V. Taucher, Johannes Haybaeck. Mechanisms of Molecular Carcinogenesis – Volume 2. 2017; : 83 doi: 10.1007/978-3-319-53661-3_5
|
| 109 |
Sven H. Loosen, Pia Hoening, Niklas Puethe, Mark Luedde, Martina Spehlmann, Tom F. Ulmer, David V. Cardenas, Sanchari Roy, Frank Tacke, Christian Trautwein, Ulf P. Neumann, Tom Luedde, Christoph Roderburg. Elevated serum levels of bone sialoprotein (BSP) predict long-term mortality in patients with pancreatic adenocarcinoma. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-018-38352-2
|
| 110 |
Can Huang, Juan Iovanna, Patricia Santofimia-Castaño. Targeting Fibrosis: The Bridge That Connects Pancreatitis and Pancreatic Cancer. International Journal of Molecular Sciences 2021; 22(9): 4970 doi: 10.3390/ijms22094970
|
| 111 |
Sameer Kumar Panda, Nirmal Robinson, Vincenzo Desiderio. Decoding secret role of mesenchymal stem cells in regulating cancer stem cells and drug resistance. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2024; 1879(6): 189205 doi: 10.1016/j.bbcan.2024.189205
|
| 112 |
Zhenli Guo, Milad Ashrafizadeh, Wei Zhang, Rongjun Zou, Gautam Sethi, Xianbin Zhang. Molecular profile of metastasis, cell plasticity and EMT in pancreatic cancer: a pre-clinical connection to aggressiveness and drug resistance. Cancer and Metastasis Reviews 2024; 43(1): 29 doi: 10.1007/s10555-023-10125-y
|
| 113 |
Michela Cortesi, Michele Zanoni, Francesca Pirini, Maria Maddalena Tumedei, Sara Ravaioli, Ilario Giovanni Rapposelli, Giovanni Luca Frassineti, Sara Bravaccini. Pancreatic Cancer and Cellular Senescence: Tumor Microenvironment under the Spotlight. International Journal of Molecular Sciences 2021; 23(1): 254 doi: 10.3390/ijms23010254
|
| 114 |
Mehmet Akce, Bassel F El-Rayes. Novel Strategies on the Horizon for Metastatic Pancreatic Cancer Management. Oncology & Hematology Review (US) 2019; 15(1): 27 doi: 10.17925/OHR.2019.15.1.27
|
| 115 |
Lily M. Channon, Victoria M. Tyma, Zhihong Xu, David W. Greening, Jeremy S. Wilson, Chamini J. Perera, Minoti V. Apte. Small extracellular vesicles (exosomes) and their cargo in pancreatic cancer: Key roles in the hallmarks of cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2022; 1877(3): 188728 doi: 10.1016/j.bbcan.2022.188728
|
| 116 |
Aysel Bayram, Sidar Bagbudar, Hasan Karanlık, Neslihan Cabıoglu, Adnan Aydıner, Semen Onder, Ekrem Yavuz. Estrogen receptor positivity in stromal cells of the tumor bed predicts the response to neoadjuvant chemotherapy for breast carcinoma. Breast Cancer Research and Treatment 2025; 210(3): 627 doi: 10.1007/s10549-024-07601-6
|
| 117 |
Shona Hendry, Roberto Salgado, Thomas Gevaert, Prudence A. Russell, Tom John, Bibhusal Thapa, Michael Christie, Koen van de Vijver, M.V. Estrada, Paula I. Gonzalez-Ericsson, Melinda Sanders, Benjamin Solomon, Cinzia Solinas, Gert G.G.M. Van den Eynden, Yves Allory, Matthias Preusser, Johannes Hainfellner, Giancarlo Pruneri, Andrea Vingiani, Sandra Demaria, Fraser Symmans, Paolo Nuciforo, Laura Comerma, E.A. Thompson, Sunil Lakhani, Seong-Rim Kim, Stuart Schnitt, Cecile Colpaert, Christos Sotiriou, Stefan J. Scherer, Michail Ignatiadis, Sunil Badve, Robert H. Pierce, Giuseppe Viale, Nicolas Sirtaine, Frederique Penault-Llorca, Tomohagu Sugie, Susan Fineberg, Soonmyung Paik, Ashok Srinivasan, Andrea Richardson, Yihong Wang, Ewa Chmielik, Jane Brock, Douglas B. Johnson, Justin Balko, Stephan Wienert, Veerle Bossuyt, Stefan Michiels, Nils Ternes, Nicole Burchardi, Stephen J. Luen, Peter Savas, Frederick Klauschen, Peter H. Watson, Brad H. Nelson, Carmen Criscitiello, Sandra O’Toole, Denis Larsimont, Roland de Wind, Giuseppe Curigliano, Fabrice André, Magali Lacroix-Triki, Mark van de Vijver, Federico Rojo, Giuseppe Floris, Shahinaz Bedri, Joseph Sparano, David Rimm, Torsten Nielsen, Zuzana Kos, Stephen Hewitt, Baljit Singh, Gelareh Farshid, Sibylle Loibl, Kimberly H. Allison, Nadine Tung, Sylvia Adams, Karen Willard-Gallo, Hugo M. Horlings, Leena Gandhi, Andre Moreira, Fred Hirsch, Maria V. Dieci, Maria Urbanowicz, Iva Brcic, Konstanty Korski, Fabien Gaire, Hartmut Koeppen, Amy Lo, Jennifer Giltnane, Marlon C. Rebelatto, Keith E. Steele, Jiping Zha, Kenneth Emancipator, Jonathan W. Juco, Carsten Denkert, Jorge Reis-Filho, Sherene Loi, Stephen B. Fox. Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors. Advances in Anatomic Pathology 2017; 24(6): 311 doi: 10.1097/PAP.0000000000000161
|
| 118 |
Yaojie Fu, Shanshan Liu, Shan Zeng, Hong Shen. The critical roles of activated stellate cells-mediated paracrine signaling, metabolism and onco-immunology in pancreatic ductal adenocarcinoma. Molecular Cancer 2018; 17(1) doi: 10.1186/s12943-018-0815-z
|
| 119 |
Kai Wang, Graham S Baldwin, Mehrdad Nikfarjam, Hong He. p21-activated kinase signalling in pancreatic cancer: New insights into tumour biology and immune modulation. World Journal of Gastroenterology 2018; 24(33): 3709-3723 doi: 10.3748/wjg.v24.i33.3709
|
| 120 |
Bekesho Geleta, Faten S. Tout, Syer Choon Lim, Sumit Sahni, Patric J. Jansson, Minoti V. Apte, Des R. Richardson, Žaklina Kovačević. Targeting Wnt/tenascin C-mediated cross talk between pancreatic cancer cells and stellate cells via activation of the metastasis suppressor NDRG1. Journal of Biological Chemistry 2022; 298(3): 101608 doi: 10.1016/j.jbc.2022.101608
|
| 121 |
Sara Fanijavadi, Mads Thomassen, Lars Henrik Jensen. Targeting Triple NK Cell Suppression Mechanisms: A Comprehensive Review of Biomarkers in Pancreatic Cancer Therapy. International Journal of Molecular Sciences 2025; 26(2): 515 doi: 10.3390/ijms26020515
|
| 122 |
Stella Totti, Spyros I. Vernardis, Lisiane Meira, Pedro A. Pérez-Mancera, Eithne Costello, William Greenhalf, Daniel Palmer, John Neoptolemos, Athanasios Mantalaris, Eirini G. Velliou. Designing a bio-inspired biomimetic in vitro system for the optimization of ex vivo studies of pancreatic cancer. Drug Discovery Today 2017; 22(4): 690 doi: 10.1016/j.drudis.2017.01.012
|
| 123 |
Daniel Ansari, Maria Carvajo, Monika Bauden, Roland Andersson. Pancreatic cancer stroma: controversies and current insights. Scandinavian Journal of Gastroenterology 2017; 52(6-7): 641 doi: 10.1080/00365521.2017.1293726
|
| 124 |
Irina Negut, Valentina Grumezescu. Biomedical Applications of Nanoparticles. 2019; : 63 doi: 10.1016/B978-0-12-816506-5.00012-7
|
| 125 |
Benedetta Ferrara, Cataldo Pignatelli, Mélissande Cossutta, Antonio Citro, José Courty, Lorenzo Piemonti. The Extracellular Matrix in Pancreatic Cancer: Description of a Complex Network and Promising Therapeutic Options. Cancers 2021; 13(17): 4442 doi: 10.3390/cancers13174442
|
| 126 |
Hiromitsu Maehira, Toru Miyake, Hiroya Iida, Aya Tokuda, Haruki Mori, Daiki Yasukawa, Ken-ichi Mukaisho, Tomoharu Shimizu, Masaji Tani. Vimentin Expression in Tumor Microenvironment Predicts Survival in Pancreatic Ductal Adenocarcinoma: Heterogeneity in Fibroblast Population. Annals of Surgical Oncology 2019; 26(13): 4791 doi: 10.1245/s10434-019-07891-x
|
| 127 |
Cuiping Qi, Di Wang, Xue Gong, Qiyang Zhou, Xinxin Yue, Chenglei Li, Zhipeng Li, Guixiang Tian, Bo Zhang, Qing Wang, Xiuhong Wei, Jingliang Wu. Co-Delivery of Curcumin and Capsaicin by Dual-Targeting Liposomes for Inhibition of aHSC-Induced Drug Resistance and Metastasis. ACS Applied Materials & Interfaces 2021; 13(14): 16019 doi: 10.1021/acsami.0c23137
|
| 128 |
Adrianna Zygmunt, Jerzy Gubernator. Metabolism and structure of PDA as the target for new therapies: possibilities and limitations for nanotechnology. Expert Opinion on Drug Delivery 2024; 21(6): 845 doi: 10.1080/17425247.2024.2370492
|
| 129 |
Rosalia Dieli, Rosa Lioy, Fabiana Crispo, Nicoletta Cascelli, Mara Martinelli, Rosa Lerose, Donatella Telesca, Maria Rita Milella, Marco Colella, Simona Loperte, Carmela Mazzoccoli. The Oncoprotein Mucin 1 in Pancreatic Cancer Onset and Progression: Potential Clinical Implications. Biomolecules 2025; 15(2): 275 doi: 10.3390/biom15020275
|
| 130 |
Yasuhiro Matsumura. Cancer Drug Delivery Systems Based on the Tumor Microenvironment. 2019; : 255 doi: 10.1007/978-4-431-56880-3_11
|
| 131 |
Patrizia Procacci, Claudia Moscheni, Patrizia Sartori, Michele Sommariva, Nicoletta Gagliano. Tumor–Stroma Cross-Talk in Human Pancreatic Ductal Adenocarcinoma: A Focus on the Effect of the Extracellular Matrix on Tumor Cell Phenotype and Invasive Potential. Cells 2018; 7(10): 158 doi: 10.3390/cells7100158
|
| 132 |
Seema Parte, Rama Krishna Nimmakayala, Surinder K. Batra, Moorthy P. Ponnusamy. Acinar to ductal cell trans-differentiation: A prelude to dysplasia and pancreatic ductal adenocarcinoma. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2022; 1877(1): 188669 doi: 10.1016/j.bbcan.2021.188669
|
| 133 |
Emma Eriksson, Ioanna Milenova, Jessica Wenthe, Rafael Moreno, Ramon Alemany, Angelica Loskog. IL-6 Signaling Blockade during CD40-Mediated Immune Activation Favors Antitumor Factors by Reducing TGF-β, Collagen Type I, and PD-L1/PD-1. The Journal of Immunology 2019; 202(3): 787 doi: 10.4049/jimmunol.1800717
|
| 134 |
Emanuela Dell’Aquila, Claudia Angela Maria Fulgenzi, Alessandro Minelli, Fabrizio Citarella, Marco Stellato, Francesco Pantano, Marco Russano, Maria Concetta Cursano, Andrea Napolitano, Tea Zeppola, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini. Prognostic and predictive factors in pancreatic cancer. Oncotarget 2020; 11(10): 924 doi: 10.18632/oncotarget.27518
|
| 135 |
Hongyu Li, Lixiong Gao, Jinlin Du, Tianju Ma, Zi Ye, Zhaohui Li. To Better Generate Organoids, What Can We Learn From Teratomas?. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.700482
|
| 136 |
Andrii Khomiak, Marius Brunner, Maximilian Kordes, Stina Lindblad, Rainer Christoph Miksch, Daniel Öhlund, Ivonne Regel. Recent Discoveries of Diagnostic, Prognostic and Predictive Biomarkers for Pancreatic Cancer. Cancers 2020; 12(11): 3234 doi: 10.3390/cancers12113234
|
| 137 |
Mohini Singh, Paulami Pal, Rajat Subhra Dutta, Daphisha Marbaniang, Subhabrata Ray, Bhaskar Mazumder. Nanodiamond Mediated Molecular Targeting in Pancreatic Ductal Adenocarcinoma:
Disrupting the Tumor-stromal Cross-talk, Next Hope on the
Horizon?. Current Cancer Drug Targets 2023; 23(8): 620 doi: 10.2174/1568009623666230227120837
|
| 138 |
Wen-Quan Wang, Liang Liu, Jin-Zhi Xu, Xian-Jun Yu. Reflections on depletion of tumor stroma in pancreatic cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2019; 1871(2): 267 doi: 10.1016/j.bbcan.2019.01.007
|
| 139 |
Eleonora Rofi, Caterina Vivaldi, Marzia Del Re, Elena Arrigoni, Stefania Crucitta, Niccola Funel, Stefano Fogli, Enrico Vasile, Gianna Musettini, Lorenzo Fornaro, Alfredo Falcone, Romano Danesi. The Emerging Role of Liquid Biopsy in Diagnosis, Prognosis and Treatment Monitoring of Pancreatic Cancer. Pharmacogenomics 2019; 20(1): 49 doi: 10.2217/pgs-2018-0149
|
| 140 |
Enrica Saponara, Michele Visentin, Francesco Baschieri, Gitta Seleznik, Paola Martinelli, Irene Esposito, Johanna Buschmann, Rong Chen, Rossella Parrotta, Nathalie Borgeaud, Marta Bombardo, Ermanno Malagola, Amedeo Caflisch, Hesso Farhan, Rolf Graf, Sabrina Sonda. Serotonin uptake is required for Rac1 activation in Kras‐induced acinar‐to‐ductal metaplasia in the pancreas. The Journal of Pathology 2018; 246(3): 352 doi: 10.1002/path.5147
|
| 141 |
Rui Tang, Christopher W Murray, Ian L Linde, Nicholas J Kramer, Zhonglin Lyu, Min K Tsai, Leo C Chen, Hongchen Cai, Aaron D Gitler, Edgar Engleman, Wonjae Lee, Monte M Winslow. A versatile system to record cell-cell interactions. eLife 2020; 9 doi: 10.7554/eLife.61080
|
| 142 |
Nilesh U. Deshpande, Anna Bianchi, Haleh Amirian, Iago De Castro Silva, Christine I. Rafie, Bapurao Surnar, Karthik Rajkumar, Akash Ashokan, Ifeanyichukwu C. Ogobuiro, Manan Patel, Erietta Stelekati, Shanta Dhar, Jashodeep Datta. Cell-specific nanoengineering strategy to disrupt tolerogenic signaling from myeloid-derived suppressor cells and invigorate antitumor immunity in pancreatic cancer. Cancer Immunology, Immunotherapy 2025; 74(8) doi: 10.1007/s00262-025-04096-y
|
| 143 |
Marlene Geyer, Daniel Schreyer, Lisa-Marie Gaul, Susanne Pfeffer, Christian Pilarsky, Karla Queiroz. A microfluidic-based PDAC organoid system reveals the impact of hypoxia in response to treatment. Cell Death Discovery 2023; 9(1) doi: 10.1038/s41420-023-01334-z
|
| 144 |
Afsane Bahrami, Majid Khazaei, Fariba Bagherieh, Majid Ghayour‐Mobarhan, Mina Maftouh, Seyed Mahdi Hassanian, Amir Avan. Targeting stroma in pancreatic cancer: Promises and failures of targeted therapies. Journal of Cellular Physiology 2017; 232(11): 2931 doi: 10.1002/jcp.25798
|
| 145 |
Jennifer L. Miller-Ocuin, Xiaoyan Liang, Brian A. Boone, W. Reed Doerfler, Aatur D. Singhi, Daolin Tang, Rui Kang, Michael T. Lotze, Herbert J. Zeh. DNA released from neutrophil extracellular traps (NETs) activates pancreatic stellate cells and enhances pancreatic tumor growth. OncoImmunology 2019; 8(9): e1605822 doi: 10.1080/2162402X.2019.1605822
|
| 146 |
M Pergamo, G Miller. Myeloid-derived suppressor cells and their role in pancreatic cancer. Cancer Gene Therapy 2017; 24(3): 100 doi: 10.1038/cgt.2016.65
|
| 147 |
Giulio Gabbiani, Matteo Coen, Fabio Zampieri. Wound Healing, Fibrosis, and the Myofibroblast. 2022; : 27 doi: 10.1016/B978-0-323-90546-6.00007-1
|
| 148 |
Marzia Conte, Valentina Cauda. Multimodal Therapies against Pancreatic Ductal Adenocarcinoma: A Review on Synergistic Approaches toward Ultimate Nanomedicine Treatments. Advanced Therapeutics 2022; 5(11) doi: 10.1002/adtp.202200079
|
| 149 |
Mohammad Awaji, Rakesh K. Singh. Cancer-Associated Fibroblasts’ Functional Heterogeneity in Pancreatic Ductal Adenocarcinoma. Cancers 2019; 11(3): 290 doi: 10.3390/cancers11030290
|
| 150 |
Junpei Yamaguchi, Yukihiro Yokoyama, Toshio Kokuryo, Tomoki Ebata, Atsushi Enomoto, Masato Nagino. Trefoil factor 1 inhibits epithelial-mesenchymal transition of pancreatic intraepithelial neoplasm. Journal of Clinical Investigation 2018; 128(8): 3619 doi: 10.1172/JCI97755
|
| 151 |
Yang Li, Hao-yu Duan, Kai-di Yang, Jun-feng Ye. Advancements and challenges in oncolytic virus therapy for gastrointestinal tumors. Biomedicine & Pharmacotherapy 2023; 168: 115627 doi: 10.1016/j.biopha.2023.115627
|
| 152 |
Zhaowei Sun, Dong Sun, Yujie Feng, Bingyuan Zhang, Peng Sun, Bin Zhou, Lutao Du, Yunshan Wang, Zhiyao Fan, Jian Yang, Yongzheng Li, Sanyuan Hu, Hanxiang Zhan. Exosomal linc-ROR mediates crosstalk between cancer cells and adipocytes to promote tumor growth in pancreatic cancer. Molecular Therapy - Nucleic Acids 2021; 26: 253 doi: 10.1016/j.omtn.2021.06.001
|
| 153 |
Ivana Acimovic, Viktorie Gabrielová, Stanislava Martínková, Michal Eid, Jakub Vlažný, Petr Moravčík, Jan Hlavsa, Lukáš Moráň, Riza Can Cakmakci, Peter Staňo, Vladimír Procházka, Zdeněk Kala, Jan Trnka, Petr Vaňhara. Ex-Vivo 3D Cellular Models of Pancreatic Ductal Adenocarcinoma. Pancreas 2025; 54(1): e57 doi: 10.1097/MPA.0000000000002393
|
| 154 |
Claudia Minici, Elena Rigamonti, Marco Lanzillotta, Antonella Monno, Lucrezia Rovati, Takashi Maehara, Naoki Kaneko, Vikram Deshpande, Maria Pia Protti, Lucia De Monte, Cristina Scielzo, Stefano Crippa, Paolo Giorgio Arcidiacono, Erica Dugnani, Lorenzo Piemonti, Massimo Falconi, Shiv Pillai, Angelo A. Manfredi, Emanuel Della-Torre. B lymphocytes contribute to stromal reaction in pancreatic ductal adenocarcinoma. OncoImmunology 2020; 9(1) doi: 10.1080/2162402X.2020.1794359
|
| 155 |
Sandeep Kumar, Sunil Kumar Singh, Piush Srivastava, Swathi Suresh, Basabi Rana, Ajay Rana. Pancreatic Cancer: Basic Mechanisms and Therapies. Advances in Cancer Research 2023; 159: 113 doi: 10.1016/bs.acr.2023.02.003
|
| 156 |
Sascha Rahn, Philippe Dänzer Barbosa, Julia Luisa Möller, Nourhane Ammar, Tobias Demetrowitsch, Ole Helm, Daniela Wesch, Bence Sipos, Christoph Röcken, Karin Schwarz, Heiner Schäfer, Susanne Sebens. Inflammation Associated Pancreatic Tumorigenesis: Upregulation of Succinate Dehydrogenase (Subunit B) Reduces Cell Growth of Pancreatic Ductal Epithelial Cells. Cancers 2019; 12(1): 42 doi: 10.3390/cancers12010042
|
| 157 |
Marco Tomasetti, Wan Lee, Lory Santarelli, Jiri Neuzil. Exosome-derived microRNAs in cancer metabolism: possible implications in cancer diagnostics and therapy. Experimental & Molecular Medicine 2017; 49(1): e285 doi: 10.1038/emm.2016.153
|
| 158 |
Brad Kline, Surekha Yadav, Youngho Seo, Robin Cumming Ippisch, Jessa Castillo, Rahul R. Aggarwal, Robin Kate Kelley, Spencer C. Behr, Robert R. Flavell, Courtney Lawhn-Heath, Michelle Melisko, Hope S. Rugo, Victoria Wang, Sue S. Yom, Patrick Ha, Fei Jiang, Thomas A. Hope. 68Ga-FAP-2286 PET of Solid Tumors: Biodistribution, Dosimetry, and Comparison with18F-FDG. Journal of Nuclear Medicine 2024; 65(6): 938 doi: 10.2967/jnumed.123.267281
|
| 159 |
Dan Wang, Yuqiang Li, Heming Ge, Tarik Ghadban, Matthias Reeh, Cenap Güngör. The Extracellular Matrix: A Key Accomplice of Cancer Stem Cell Migration, Metastasis Formation, and Drug Resistance in PDAC. Cancers 2022; 14(16): 3998 doi: 10.3390/cancers14163998
|
| 160 |
Pedro M. Aponte, Andrés Caicedo. Stemness in Cancer: Stem Cells, Cancer Stem Cells, and Their Microenvironment. Stem Cells International 2017; 2017: 1 doi: 10.1155/2017/5619472
|
| 161 |
Marta Overchuk, Gang Zheng. Overcoming obstacles in the tumor microenvironment: Recent advancements in nanoparticle delivery for cancer theranostics. Biomaterials 2018; 156: 217 doi: 10.1016/j.biomaterials.2017.10.024
|
| 162 |
Isabel Calejo, Marcel Alexander Heinrich, Giorgia Zambito, Laura Mezzanotte, Jai Prakash, Liliana Moreira Teixeira. Microfluidics and Biosensors in Cancer Research. Advances in Experimental Medicine and Biology 2022; 1379: 171 doi: 10.1007/978-3-031-04039-9_7
|
| 163 |
Michael Friberg Bruun Nielsen, Michael Bau Mortensen, Sönke Detlefsen. Identification of markers for quiescent pancreatic stellate cells in the normal human pancreas. Histochemistry and Cell Biology 2017; 148(4): 359 doi: 10.1007/s00418-017-1581-5
|
| 164 |
Hanyu Zhang, Min Yang, Xu Wu, Qianxiu Li, Xin Li, Yueshui Zhao, Fukuan Du, Yu Chen, Zhigui Wu, Zhangang Xiao, Jing Shen, Qinglian Wen, Wei Hu, Chi Hin Cho, Meijuan Chen, Yejiang Zhou, Mingxing Li. The distinct roles of exosomes in tumor-stroma crosstalk within gastric tumor microenvironment. Pharmacological Research 2021; 171: 105785 doi: 10.1016/j.phrs.2021.105785
|
| 165 |
Katja Schiedlauske, Alina Deipenbrock, Marc Pflieger, Alexandra Hamacher, Jan Hänsel, Matthias U. Kassack, Thomas Kurz, Nicole E. Teusch. Novel Histone Deacetylase (HDAC) Inhibitor Induces Apoptosis and Suppresses Invasion via E-Cadherin Upregulation in Pancreatic Ductal Adenocarcinoma (PDAC). Pharmaceuticals 2024; 17(6): 752 doi: 10.3390/ph17060752
|
| 166 |
Fabio Grizzi, Sirio Fiorino, Dorina Qehajaj, Adele Fornelli, Carlo Russo, Dario de Biase, Michele Masetti, Laura Mastrangelo, Matteo Zanello, Raffaele Lombardi, Andrea Domanico, Esterita Accogli, Andrea Tura, Leonardo Mirandola, Maurizio Chiriva-Internati, Robert S. Bresalier, Elio Jovine, Paolo Leandri, Luca Di Tommaso. Computer-aided assessment of the extra-cellular matrix during pancreatic carcinogenesis: a pilot study. Journal of Translational Medicine 2019; 17(1) doi: 10.1186/s12967-019-1817-3
|
| 167 |
Manoj Amrutkar, Ivar Gladhaug. Pancreatic Cancer Chemoresistance to Gemcitabine. Cancers 2017; 9(11): 157 doi: 10.3390/cancers9110157
|
| 168 |
P. C. Jiang, T. Y. Bao, J. M. Zhi, S. R. Bu. Prognostic value and immunological characteristics of a novel autophagy-related signature in pancreatic cancer. Journal of Biosciences 2021; 46(3) doi: 10.1007/s12038-021-00189-9
|
| 169 |
Yan Luo, Jisheng Hu, Yong Liu, Le Li, Yilong Li, Bei Sun, Rui Kong. Invadopodia: A potential target for pancreatic cancer therapy. Critical Reviews in Oncology/Hematology 2021; 159: 103236 doi: 10.1016/j.critrevonc.2021.103236
|
| 170 |
Hyung Sun Kim, Woojin Kim, Won-Gun Yun, Hye-Sol Jung, Youngmin Han, Mirang Lee, Wooil Kwon, Jin-Young Jang, Joon Seong Park. Novel Predictive Strategy Using CA19-9 and Fecal Elastase Levels to Make Treatment Decisions for Resectable Pancreatic Cancer: A Retrospective Study. Biomedicines 2024; 13(1): 62 doi: 10.3390/biomedicines13010062
|
| 171 |
Bin Yan, Liang Cheng, Zhengdong Jiang, Ke Chen, Cancan Zhou, Liankang Sun, Junyu Cao, Weikun Qian, Jie Li, Tao Shan, Jianjun Lei, Qingyong Ma, Jiguang Ma, Mithun Sinha. Resveratrol Inhibits ROS‐Promoted Activation and Glycolysis of Pancreatic Stellate Cells via Suppression of miR‐21. Oxidative Medicine and Cellular Longevity 2018; 2018(1) doi: 10.1155/2018/1346958
|
| 172 |
Ahmed Osman Mohamed, Rongzhuo Long, Yin He, Xiaosheng Wang. Comprehensive Analysis of Clinical and Molecular Features in Cancer Patients Associated With Major Human Oncoviruses. Journal of Medical Virology 2025; 97(2) doi: 10.1002/jmv.70239
|
| 173 |
Nicole Lintern, Andrew M. Smith, David G. Jayne, Yazan S. Khaled. Photodynamic Stromal Depletion in Pancreatic Ductal Adenocarcinoma. Cancers 2023; 15(16): 4135 doi: 10.3390/cancers15164135
|
| 174 |
Wenpan Li, Nicholas Little, Jonghan Park, Cole Alexander Foster, Jiawei Chen, Jianqin Lu. Tumor-Associated Fibroblast-Targeting Nanoparticles for Enhancing Solid Tumor Therapy: Progress and Challenges. Molecular Pharmaceutics 2021; 18(8): 2889 doi: 10.1021/acs.molpharmaceut.1c00455
|
| 175 |
Yosuke Mukai, Daisaku Yamada, Hidetoshi Eguchi, Yoshifumi Iwagami, Tadafumi Asaoka, Takehiro Noda, Koichi Kawamoto, Kunihito Gotoh, Shogo Kobayashi, Yutaka Takeda, Masahiro Tanemura, Masaki Mori, Yuichiro Doki. Vitamin D Supplementation is a Promising Therapy for Pancreatic Ductal Adenocarcinoma in Conjunction with Current Chemoradiation Therapy. Annals of Surgical Oncology 2018; 25(7): 1868 doi: 10.1245/s10434-018-6431-8
|
| 176 |
Richard L. Sleightholm, Beth K. Neilsen, Jing Li, Maria M. Steele, Rakesh K. Singh, Michael A. Hollingsworth, David Oupicky. Emerging roles of the CXCL12/CXCR4 axis in pancreatic cancer progression and therapy. Pharmacology & Therapeutics 2017; 179: 158 doi: 10.1016/j.pharmthera.2017.05.012
|
| 177 |
Kate Young, Daniel J. Hughes, David Cunningham, Naureen Starling. Immunotherapy and pancreatic cancer: unique challenges and potential opportunities. Therapeutic Advances in Medical Oncology 2018; 10 doi: 10.1177/1758835918816281
|
| 178 |
Veronique Veenstra, Andrea Garcia-Garijo, Hanneke Van Laarhoven, Maarten Bijlsma. Extracellular Influences: Molecular Subclasses and the Microenvironment in Pancreatic Cancer. Cancers 2018; 10(2): 34 doi: 10.3390/cancers10020034
|
| 179 |
Jiamin Jin, Jiacheng Cong, Shangbo Lei, Qiujin Zhang, Xinyi Zhong, Yingying Su, Mingchuan Lu, Yifen Ma, Zihe Li, Liyan Wang, Ningxia Zhu, Jinfeng Yang. Cracking the code: Deciphering the role of the tumor microenvironment in osteosarcoma metastasis. International Immunopharmacology 2023; 121: 110422 doi: 10.1016/j.intimp.2023.110422
|
| 180 |
Thomas M. Pausch, Elisa Aue, Naita M. Wirsik, Aida Freire Valls, Ying Shen, Praveen Radhakrishnan, Thilo Hackert, Martin Schneider, Thomas Schmidt. Metastasis-associated fibroblasts promote angiogenesis in metastasized pancreatic cancer via the CXCL8 and the CCL2 axes. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-62416-x
|
| 181 |
Vijay Sagar Madamsetty, Krishnendu Pal, Shamit Kumar Dutta, Enfeng Wang, Debabrata Mukhopadhyay. Targeted Dual Intervention-Oriented Drug-Encapsulated (DIODE) Nanoformulations for Improved Treatment of Pancreatic Cancer. Cancers 2020; 12(5): 1189 doi: 10.3390/cancers12051189
|
| 182 |
Ayça Arçay Öztürk, Patrick Flamen. FAP-targeted PET imaging in gastrointestinal malignancies: a comprehensive review. Cancer Imaging 2023; 23(1) doi: 10.1186/s40644-023-00598-z
|